126 related articles for article (PubMed ID: 15461812)
21. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein M.
Ren K; Tang ZL; Jiang Y; Tan YM; Yi GH
Clin Chim Acta; 2015 Jun; 446():21-9. PubMed ID: 25858547
[TBL] [Abstract][Full Text] [Related]
23. Characterization of apoM in normal and genetically modified mice.
Faber K; Axler O; Dahlbäck B; Nielsen LB
J Lipid Res; 2004 Jul; 45(7):1272-8. PubMed ID: 15102887
[TBL] [Abstract][Full Text] [Related]
24. [Effect of interfering hepatocyte nuclear factor-1 alfa in HepG2 on the expressions of apoM, apoA-I and the correlative key enzyme of cholesterol metabolism].
Zhang Y; Chen CJ; Yang QL; Cheng LQ; Wang H; Huang LZ
Zhonghua Gan Zang Bing Za Zhi; 2011 Feb; 19(2):121-6. PubMed ID: 21492516
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
26. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo.
Xu N; Nilsson-Ehle P; Hurtig M; Ahrén B
Biochem Biophys Res Commun; 2004 Sep; 321(4):916-21. PubMed ID: 15358114
[TBL] [Abstract][Full Text] [Related]
27. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.
Christoffersen C; Ahnström J; Axler O; Christensen EI; Dahlbäck B; Nielsen LB
J Biol Chem; 2008 Jul; 283(27):18765-72. PubMed ID: 18460466
[TBL] [Abstract][Full Text] [Related]
28. Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1beta and HNF-1alpha and the abnormality of HNF-1beta mutants.
Kitanaka S; Sato U; Igarashi T
J Endocrinol; 2007 Jan; 192(1):141-7. PubMed ID: 17210751
[TBL] [Abstract][Full Text] [Related]
29. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.
Rausa F; Samadani U; Ye H; Lim L; Fletcher CF; Jenkins NA; Copeland NG; Costa RH
Dev Biol; 1997 Dec; 192(2):228-46. PubMed ID: 9441664
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein M: Research Progress and Clinical Perspective.
Luo G; Xu N
Adv Exp Med Biol; 2020; 1276():85-103. PubMed ID: 32705596
[TBL] [Abstract][Full Text] [Related]
31. Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice.
Tsuji K; Maeda T; Kawane T; Matsunuma A; Horiuchi N
J Bone Miner Res; 2010 Aug; 25(8):1711-23. PubMed ID: 20200981
[TBL] [Abstract][Full Text] [Related]
32. Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M.
Wolfrum C; Howell JJ; Ndungo E; Stoffel M
J Biol Chem; 2008 Jun; 283(24):16940-9. PubMed ID: 18381283
[TBL] [Abstract][Full Text] [Related]
33. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro.
Zhang X; Jiang B; Luo G; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2007 Jul; 1771(7):879-82. PubMed ID: 17556016
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of serum apolipoprotein M level.
Tanaka S; Okamoto Y
Clin Lab; 2011; 57(9-10):803-6. PubMed ID: 22029201
[TBL] [Abstract][Full Text] [Related]
35. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
36. Mouse ApoM displays an unprecedented seven-stranded lipocalin fold: folding decoy or alternative native fold?
Sevvana M; Kassler K; Ahnström J; Weiler S; Dahlbäck B; Sticht H; Muller YA
J Mol Biol; 2010 Dec; 404(3):363-71. PubMed ID: 20932978
[TBL] [Abstract][Full Text] [Related]
37. Expression of apolipoprotein M and its association with adiponectin in an obese mouse model.
Yang L; Li T; Zhao S; Zhang S
Exp Ther Med; 2019 Sep; 18(3):1685-1692. PubMed ID: 31410126
[TBL] [Abstract][Full Text] [Related]
38. Expression profile of MODY3/HNF-1alpha protein in the developing mouse pancreas.
Nammo T; Yamagata K; Hamaoka R; Zhu Q; Akiyama TE; Gonzalez FJ; Miyagawa J; Matsuzawa Y
Diabetologia; 2002 Aug; 45(8):1142-53. PubMed ID: 12189445
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of apolipoprotein M as a biomarker of coronary artery disease.
Su W; Jiao G; Yang C; Ye Y
Clin Biochem; 2009 Mar; 42(4-5):365-70. PubMed ID: 19100249
[TBL] [Abstract][Full Text] [Related]
40. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor.
Shimamura M; Matsuda M; Ando Y; Koishi R; Yasumo H; Furukawa H; Shimomura I
Biochem Biophys Res Commun; 2004 Sep; 322(3):1080-5. PubMed ID: 15336575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
